-
Published 3/22/2026
Huang Y, Santoni G, Petrick JL, Wocalewski V, Sparrelid E, Xie SH. Menopausal hormone therapy and risk of liver cancer in a swedish population-based cohort study. J Natl Cancer Inst. 2026 Mar 22. PMID: 41866298.
-
Published 1/22/2026
Manful A, Amanna N, Park SL, Petrick JL, Rosenberg L, Tindle H, Palmer J, Wilkens L, Le Marchand L, Aldrich MC, Blume JD. The Impact of the 2023 American Cancer Society Screening Recommendations on Racial, Ethnic, and Sex Disparities in Lung Cancer Screening Eligibility. Chest. 2026 Jan 22. PMID: 41580073.
-
Published 12/22/2025
Alvarez CS, Wojt A, Almeida AA, Miller JS, Graubard BI, Petrick JL, McGlynn KA. Rising Intrahepatic Cholangiocarcinoma Rates in the United States Are Driving Liver Cancer Rates in Females. Clin Gastroenterol Hepatol. 2025 Dec 22. PMID: 41443525.
-
Published 12/1/2025
Lima SM, Minlikeeva AN, Johnson CE, Guertin KA, Bandera EV, Zheng W, Bethea TN, Petrick JL, Joslin CE, Myers ER, Harris HR, Peres LC, Setiawan VW, Wu AH, Rosenberg L, Schildkraut JM, Ochs-Balcom HM. Regular Physical Inactivity and Ovarian Cancer Risk in the Ovarian Cancer in Women of African Ancestry Consortium. Cancer Epidemiol Biomarkers Prev. 2025 Dec 01; 34(12):2302-2305. PMID: 40956289.
-
Published 10/23/2025
Watling CZ, Campbell PT, Graubard BI, Wang Y, Gewirtz AT, Zhang X, Barnett MJ, Buring JE, Chen Y, Eliassen AH, Gaziano JM, Hofmann JN, Huang WY, Kang JH, Koshiol J, Loftfield E, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Purdue MP, Sesso HD, Shrubsole M, Sinha R, Tinker L, Triplette M, Um CY, Visvanathan K, Watts EL, Wactawski-Wende J, Willett W, Wu F, Zheng W, Barupal D, Petrick JL, McGlynn KA. Pre-diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case-control analysis of 12 prospective cohorts. Int J Cancer. 2026 Apr 01; 158(7):1801-1812. PMID: 41129365.